Confidentiality Notice
Last Updated: March 2026
5.1 Purpose and Scope
This Confidentiality Notice explains how Cadenza treats information received through website inquiries and pre-contract communications. Because website forms are inherently less secure than executed confidentiality agreements, this Notice is designed to set expectations and protect both parties’ interests pending formal documentation.
5.2 Treatment of Submitted Information
Cadenza treats inquiry submissions and communications as commercially sensitive and restricts access internally on a need-to-know basis. Such information may be reviewed by authorized personnel and professional advisors under confidentiality as required to evaluate feasibility and respond.
5.3 No Automatic NDA
Submitting information through the website does not automatically create a legally binding NDA. Formal confidentiality obligations are established only through a written NDA or a signed commercial agreement containing confidentiality clauses, except where confidentiality is mandated by law.
5.4 What You Should Not Submit via Website Forms
To reduce risk, you should not submit complete formulations, trade secrets, proprietary lab reports, or any materials that require heightened protection unless and until a written NDA is executed. If you choose to submit such materials without an NDA, you do so at your own risk.
5.5 Legal Protection of Cadenza IP
Cadenza’s formulation know-how, documentation formats, base systems, and technical frameworks are proprietary and protected under intellectual property laws. Unauthorized copying, reverse engineering, or misuse is prohibited and may result in civil and criminal remedies. “CADENZA” is a registered trademark in India.
5.6 Governing Law and Jurisdiction
This Confidentiality Notice is governed by Indian law with exclusive jurisdiction in the competent courts of Daman, India. No arbitration applies.
Governed by Indian law • Exclusive jurisdiction: Daman, India • No arbitration